All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 61 points (-0.4%) at 16,838 as of Thursday, March 3, 2016, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,819 issues advancing vs. 1,100 declining with 146 unchanged.

The Health Care sector currently sits up 0.1% versus the S&P 500, which is down 0.4%. A company within the sector that increased today was Express Scripts ( ESRX), up 1.4%. On the negative front, top decliners within the sector include Shire ( SHPG), down 3.2%, Regeneron Pharmaceuticals ( REGN), down 2.9%, Abbott Laboratories ( ABT), down 2.9%, Novo Nordisk A/S ( NVO), down 2.6% and Valeant Pharmaceuticals International ( VRX), down 2.5%.

TheStreet would like to highlight 3 stocks pushing the sector higher today:

3. Universal Health Services ( UHS) is one of the companies pushing the Health Care sector higher today. As of noon trading, Universal Health Services is up $3.24 (2.8%) to $118.60 on average volume. Thus far, 298,415 shares of Universal Health Services exchanged hands as compared to its average daily volume of 769,600 shares. The stock has ranged in price between $115.12-$119.20 after having opened the day at $115.50 as compared to the previous trading day's close of $115.36.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. Universal Health Services has a market cap of $11.1 billion and is part of the health services industry. Shares are down 3.5% year-to-date as of the close of trading on Wednesday. Currently there are 9 analysts who rate Universal Health Services a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates Universal Health Services as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, notable return on equity, growth in earnings per share and solid stock price performance. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Universal Health Services Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, DaVita HealthCare Partners ( DVA) is up $1.56 (2.3%) to $69.74 on light volume. Thus far, 535,743 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $68.10-$69.88 after having opened the day at $68.10 as compared to the previous trading day's close of $68.18.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates in two divisions, Kidney Care and HealthCare Partners. DaVita HealthCare Partners has a market cap of $14.1 billion and is part of the health services industry. Shares are down 2.2% year-to-date as of the close of trading on Wednesday. Currently there are 6 analysts who rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full DaVita HealthCare Partners Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, HCA Holdings ( HCA) is up $1.22 (1.7%) to $72.52 on light volume. Thus far, 1.3 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.9 million shares. The stock has ranged in price between $71.12-$72.88 after having opened the day at $71.23 as compared to the previous trading day's close of $71.30.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $28.1 billion and is part of the health services industry. Shares are up 5.4% year-to-date as of the close of trading on Wednesday. Currently there are 13 analysts who rate HCA Holdings a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates HCA Holdings as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, increase in net income and revenue growth. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full HCA Holdings Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).